Nongenomic thyroid hormone signaling occurs through a plasma membrane -Localized receptor

Science Signaling

Volumn 7, Issue 326, 2014, Pages

  Kalyanaraman, Hema ^a   Schwappacher, Raphaela ^a   Joshua, Jisha ^a   Zhuang, Shunhui ^a   Scott, Brian T ^a   Klos, Matthew ^b   Casteel, Darren E ^a   Frangos, John A ^c   Dillmann, Wolfgang ^a   Boss, Gerry R ^a   Pilz, Renate B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE 2; GUANYLATE CYCLASE; METHIONINE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; PROTEIN KINASE P60; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELL TYPE; HUMAN; HUMAN CELL; HYPOTHYROIDISM; INTRACELLULAR SIGNALING; NONHUMAN; OSSIFICATION; OSTEOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; ADULT; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; GENETICS; METABOLISM; MOUSE; RAT; TRANSGENIC MOUSE;

ADULT; ANIMALS; CELLS, CULTURED; HUMANS; HYPOTHYROIDISM; MAP KINASE SIGNALING SYSTEM; MEMBRANE MICRODOMAINS; MICE; MICE, TRANSGENIC; OSTEOCYTES; OSTEOGENESIS; RATS; RECEPTORS, THYROID HORMONE; THYROID HORMONES;

EID: 84901202692     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004911     Document Type: Article

References (44)

1. S. Y. Cheng, J. L. Leonard, P. J. Davis, Molecular aspects of thyroid hormone actions. Endocr. Rev. 31, 139-170 (2010).
2. G. A. Brent, Mechanisms of thyroid hormone action. J. Clin. Invest. 122, 3035-3043 (2012).
3. F. Flamant, J. Samarut, Thyroid hormone receptors: Lessons from knockout and knock-in mutant mice. Trends Endocrinol. Metab. 14, 85-90 (2003).
4. J. Segal, S. H. Ingbar, Evidence that an increase in cytoplasmic calcium is the initiating event in certain plasma membrane-mediated responses to 3,5,3′-triiodothyronine in rat thymocytes. Endocrinology 124, 1949-1955 (1989).
5. V. A. Del, A. Secondo, A. Esposito, F. Goglia, M. Moreno, L. M. Canzoniero, Intracellular and plasma membrane-initiated pathways involved in the [Ca2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells. Am. J. Physiol. Endocrinol. Metab. 302, E1419-E1430 (2012).
6. Y. Hiroi, H. H. Kim, H. Ying, F. Furuya, Z. Huang, T. Simoncini, K. Noma, K. Ueki, N. H. Nguyen, T. S. Scanlan, M. A. Moskowitz, S. Y. Cheng, J. K. Liao, Rapid nongenomic actions of thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 103, 14104-14109 (2006).
7. H. Y. Lin, M. Sun, H. Y. Tang, C. Lin, M. K. Luidens, S. A.Mousa, S. Incerpi, G. L. Drusano, F. B. Davis, P. J. Davis, L-Thyroxine vs. 3,5,3′-triiodo-L-thyronine and cell proliferation: Activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am. J. Physiol. Cell Physiol. 296, C980-C991 (2009).
8. S. A. Mousa, L. O'Connor, F. B. Davis, P. J. Davis, Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 147, 1602-1607 (2006).
9. A. Makino, J. Suarez, H. Wang, D. D. Belke, B. T. Scott, W. H. Dillmann, Thyroid hormone receptor-β is associated with coronary angiogenesis during pathological cardiac hypertrophy. Endocrinology 150, 2008-2015 (2009).
10. J. J. Bergh, H. Y. Lin, L. Lansing, S. N. Mohamed, F. B. Davis, S. Mousa, P. J. Davis, Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146, 2864-2871 (2005).
11. G. Hennemann, R. Docter, E. C. Friesema, J. M. de, E. P. Krenning, T. J. Visser, Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr. Rev. 22, 451-476 (2001).
12. A. I. Gogakos, J. H. Duncan Bassett, G. R. Williams, Thyroid and bone. Arch. Biochem. Biophys. 503, 129-136 (2010).
13. H. Rangaswami, N. Marathe, S. Zhuang, Y. Chen, J. C. Yeh, J. A. Frangos, G. R. Boss, R. B. Pilz, Type II cGMP-dependent protein kinase mediates osteoblast mechanotransduction. J. Biol. Chem. 284, 14796-14808 (2009).
14. H. Rangaswami, R. Schwappacher, N. Marathe, S. Zhuang, D. E. Casteel, B. Haas, Y. Chen, A. Pfeifer, H. Kato, S. Shattil, G. R. Boss, R. B. Pilz, Cyclic GMP and protein kinase G control a Src-containing mechanosome in osteoblasts. Sci. Signal. 3, ra91 (2010).
15. H. Rangaswami, R. Schwappacher, T. Tran, G. C. Chan, S. Zhuang, G. R. Boss, R. B. Pilz, Protein kinase G and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in osteoblast mechanotransduction. J. Biol. Chem. 287, 21509-21519 (2012).
16. E. J. Koury, A. C. Pawlyk, T. J. Berrodin, C. L. Smolenski, S. Nagpal, D. C. Deecher, Characterization of ligands for thyroid receptor subtypes and their interactions with co-regulators. Steroids 74, 270-276 (2009).
17. F. Casas, P. Rochard, A. Rodier, I. Cassar-Malek, S. Marchal-Victorion, R. J. Wiesner, G. Cabello, C. Wrutniak, A variant form of the nuclear triiodothyronine receptor c-ErbAα1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol. Cell. Biol. 19, 7913-7924 (1999).
18. G. A. Bazykin, A. V. Kochetov, Alternative translation start sites are conserved in eukaryotic genomes. Nucleic Acids Res. 39, 567-577 (2011).
19. A. M. Zavacki, J. W. Harney, G. A. Brent, P. R. Larsen, Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific. Mol. Endocrinol. 7, 1319-1330 (1993).
20. F. Galbiati, B. Razani, M. P. Lisanti, Emerging themes in lipid rafts and caveolae. Cell 106, 403-411 (2001).
21. S. Tuomi, A. Mai, J. Nevo, J. O. Laine, V. Vilkki, T. J. Ohman, C. G. Gahmberg, P. J. Parker, J. Ivaska, PKCε regulation of an α5 integrin - ZO-1 complex controls lamellae formation in migrating cancer cells. Sci. Signal. 2, ra32 (2009).
22. K. R. Solomon, T. E. Danciu, L. D. Adolphson, L. E. Hecht, P. V. Hauschka, Caveolin-enriched membrane signaling complexes in human and murine osteoblasts. J. Bone Miner. Res. 15, 2380-2390 (2000).
23. M. Schleicher, J. Yu, T. Murata, B. Derakhshan, D. Atochin, L. Qian, S. Kashiwagi, L. A. Di, K. D. Harrison, P. L. Huang, W. C. Sessa, The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci. Signal. 2, ra41 (2009).
24. J. M. Kindblom, E. F. Gevers, S. M. Skrtic, M. K. Lindberg, S. Göthe, J. Törnell, B. Vennström, C. Ohlsson, Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. Bone 36, 607-616 (2005).
25. F. N. Salloum, A. Das, A. Samidurai, N. N. Hoke, V. Q. Chau, R. A. Ockaili, J. P. Stasch, R. C. Kukreja, Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: Role of hydrogen sulfide. Am. J. Physiol. Heart Circ. Physiol. 302, H1347-H1354 (2012).
26. A. Quesada, J. Sainz, R. Wangensteen, I. Rodriguez-Gomez, F. Vargas, A. Osuna, Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur. J. Endocrinol. 147, 117-122 (2002).
27. J. Bigler, W. Hokanson, R. N. Eisenman, Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor. Mol. Cell. Biol. 12, 2406-2417 (1992).
28. A. Kenessey, K. Ojamaa, Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J. Biol. Chem. 281, 20666-20672 (2006).
29. X. Cao, F. Kambe, L. C. Moeller, S. Refetoff, H. Seo, Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Mol. Endocrinol. 19, 102-112 (2005).
30. N. M. Storey, S. Gentile, H. Ullah, A. Russo, M. Muessel, C. Erxleben, D. L. Armstrong, Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 103, 5197-5201 (2006).
31. F. C. Verga, V. Patriarca, B. Bucci, C. Mangialardo, S. Michienzi, G. Moriggi, A. Stigliano, E. Brunetti, V. Toscano, S. Misiti, The TRβ1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells. J. Cell. Biochem. 106, 835-848 (2009).
32. F. Furuya, J. A. Hanover, S. Y. Cheng, Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor. Proc. Natl. Acad. Sci. U.S.A. 103, 1780-1785 (2006).
33. E. R. Levin, Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 20, 477-482 (2009).
34. A. Pedram, M. Razandi, R. C. Sainson, J. K. Kim, C. C. Hughes, E. R. Levin, A conserved mechanism for steroid receptor translocation to the plasma membrane. J. Biol. Chem. 282, 22278-22288 (2007).
35. R. L. Wagner, J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, R. J. Fletterick, A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697 (1995).
36. S. Kousteni, T. Bellido, L. I. Plotkin, C. A. O 'Brien, D. L. Bodenner, L. Han, K. Han, G. B. DiGregorio, J. A. Katzenellenbogen, B. S. Katzenellenbogen, P. K. Roberson, R. S. Weinstein, R. L. Jilka, S. C. Manolagas, Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity. Cell 104, 719-730 (2001).
37. B. M. Schmidt, N. Martin, A. C. Georgens, H. C. Tillmann, M. Feuring, M. Christ, M. Wehling, Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J. Clin. Endocrinol. Metab. 87, 1681-1686 (2002).
38. S. A. Jamal, C. J. Hamilton, Nitric oxide donors for the treatment of osteoporosis. Curr. Osteoporos. Rep. 10, 86-92 (2012).
39. D. D. Belke, B. Gloss, E. A. Swanson, W. H. Dillmann, Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-α1 and -β1 improves contractile function in pressure overload-induced cardiac hypertrophy. Endocrinology 148, 2870-2877 (2007).
40. E. J. Smart, Y. S. Ying, C. Mineo, R. G. Anderson, A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc. Natl. Acad. Sci. U.S.A. 92, 10104-10108 (1995).
41. S. Scapin, S. Leoni, S. Spagnuolo, A. M. Fiore, S. Incerpi, Short-term effects of thyroid hormones on Na+-K+-ATPase activity of chick embryo hepatocytes during development: Focus on signal transduction. Am. J. Physiol. Cell Physiol. 296, C4-C12 (2009).
42. M. Watkins, S. K. Grimston, J. Y. Norris, B. Guillotin, A. Shaw, E. Beniash, R. Civitelli, Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. Mol. Biol. Cell 22, 1240-1251 (2011).
43. G. Grynkiewicz, M. Poenie, R. Y. Tsien, A new generation of Ca 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450 (1985).
44. D. W. Dempster, J. E. Compston, M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott, R. R. Recker, A. M. Parfitt, Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2-17 (2013).